| RS149324363 |
PUS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS149325238 |
TTC21B
|
Health Risk |
Conflicting classifications of pathogenicity |
Nephronophthisis 12, Asphyxiating thoracic dystrophy 4 |
| RS149326194 |
MCM3AP
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, MCM3AP-related disorder |
| RS149326648 |
ENTPD1
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 64, Hereditary spastic paraplegia 64 |
| RS149327827 |
TMEM138
|
Health Risk |
Conflicting classifications of pathogenicity |
Joubert syndrome 16, Joubert syndrome 16 |
| RS149328427 |
KIF21A
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital fibrosis of extraocular muscles type 1, Inborn genetic diseases |
| RS149328619 |
FUT8
|
Health Risk |
Conflicting classifications of pathogenicity |
FUT8-related disorder, Congenital disorder of glycosylation with defective fucosylation 1 |
| RS149329415 |
HMCN1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS149329546 |
LEPR
|
Health Risk |
Conflicting classifications of pathogenicity |
Monogenic diabetes, LEPR-related disorder |
| RS149329669 |
ALMS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Alstrom syndrome, Cardiovascular phenotype |
| RS149330063 |
SYNE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive ataxia, Beauce type |
| RS149330066 |
VAV1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS149330072 |
ZFYVE26
|
Health Risk |
Conflicting classifications of pathogenicity |
Spastic paraplegia, Inborn genetic diseases |
| RS149330325 |
COL6A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Bethlem myopathy 1A, Collagen 6-related myopathy |
| RS149330798 |
DNASE1L3
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS149330893 |
BRCA2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary breast ovarian cancer syndrome |
| RS149331149 |
COL6A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Bethlem myopathy 1A, Inborn genetic diseases |
| RS149331537 |
RAD51C
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Fanconi anemia complementation group O |
| RS149331610 |
DHX37
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with brain anomalies and with or without vertebral or cardiac anomalies, Neurodevelopmental disorder with brain anomalies and with or without vertebral or cardiac anomalies |
| RS149333409 |
PRDM16
|
Health Risk |
Conflicting classifications of pathogenicity |
Left ventricular noncompaction 8, PRDM16-related disorder |
| RS149334616 |
VPS13B
|
Health Risk |
Conflicting classifications of pathogenicity |
Cohen syndrome, Inborn genetic diseases |
| RS149334737 |
GPR101
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS149335121 |
TRPM4
|
Health Risk |
Conflicting classifications of pathogenicity |
Progressive familial heart block type IB, Cardiovascular phenotype |
| RS149335528 |
COQ8A
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS149336067 |
CD81
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS149338158 |
COL6A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Collagen 6-related myopathy, Bethlem myopathy 1A |
| RS149338401 |
KCNE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Long QT syndrome, Cardiovascular phenotype |
| RS149338478 |
NOD2
|
Health Risk |
Conflicting classifications of pathogenicity |
Blau syndrome, Inflammatory bowel disease 1 |
| RS149339264 |
LMNA
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 2, Cardiovascular phenotype |
| RS149340262 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Hereditary cancer-predisposing syndrome |
| RS149342331 |
DST
|
Health Risk |
Conflicting classifications of pathogenicity |
Epidermolysis bullosa simplex 3, localized or generalized intermediate |
| RS149342494 |
CTF1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS149342980 |
MUTYH
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 2 |
| RS149344567 |
KCND3
|
Health Risk |
Conflicting classifications of pathogenicity |
Brugada syndrome 9, Cardiovascular phenotype |
| RS149344570 |
EVC
|
Health Risk |
Conflicting classifications of pathogenicity |
Ellis-van Creveld syndrome, Curry-Hall syndrome |
| RS149344911 |
CYBA
|
Health Risk |
Conflicting classifications of pathogenicity |
Granulomatous disease, chronic |
| RS149346187 |
CERKL
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa 26, Retinitis pigmentosa |
| RS149347582 |
DSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Arrhythmogenic right ventricular dysplasia 11, Cardiovascular phenotype |
| RS149347601 |
LAMA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital muscular dystrophy due to partial LAMA2 deficiency, LAMA2-related muscular dystrophy |
| RS149348130 |
PEX16
|
Health Risk |
Conflicting classifications of pathogenicity |
Peroxisome biogenesis disorder 8A (Zellweger), Peroxisome biogenesis disorder |
| RS149348427 |
LDB3
|
Health Risk |
Conflicting classifications of pathogenicity |
Myofibrillar myopathy 4, Dilated cardiomyopathy 1C |
| RS149348765 |
HIF1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Enchondromatosis, Enchondromatosis |
| RS149348999 |
GPI
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Hemolytic anemia due to glucophosphate isomerase deficiency |
| RS149350006 |
CEP164
|
Health Risk |
Conflicting classifications of pathogenicity |
Nephronophthisis 15, Nephronophthisis 15 |
| RS149350323 |
MSH3
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 4 |
| RS149353082 |
APC
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial adenomatous polyposis 1, Hereditary cancer-predisposing syndrome |
| RS149353780 |
GFAP
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS149354607 |
SYNE2
|
Health Risk |
Conflicting classifications of pathogenicity |
Emery-Dreifuss muscular dystrophy 5, autosomal dominant |
| RS149354918 |
ODAD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia, Primary ciliary dyskinesia 20 |
| RS149357946 |
APOB
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypercholesterolemia, familial |
| RS149358359 |
APOB
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypercholesterolemia, autosomal dominant |
| RS149358620 |
LAMA5
|
Health Risk |
Conflicting classifications of pathogenicity |
LAMA5-related disorder, Inborn genetic diseases |
| RS149358702 |
BAG3
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1HH, Myofibrillar myopathy 6 |
| RS149359120 |
RB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinoblastoma, Hereditary cancer-predisposing syndrome |
| RS149359139 |
IFT140
|
Health Risk |
Conflicting classifications of pathogenicity |
Saldino-Mainzer syndrome, Saldino-Mainzer syndrome |
| RS149359610 |
ABCC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS149359674 |
SDCCAG8
|
Health Risk |
Conflicting classifications of pathogenicity |
Senior-Loken syndrome 7, Bardet-Biedl syndrome 16 |
| RS149359860 |
PDE6B
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital stationary night blindness autosomal dominant 2, Retinitis pigmentosa |
| RS149359927 |
WRAP53
|
Health Risk |
Conflicting classifications of pathogenicity |
Dyskeratosis congenita, WRAP53-related disorder |
| RS149360088 |
NCKAP1L
|
Health Risk |
Conflicting classifications of pathogenicity |
NCKAP1L-related disorder, NCKAP1L-related disorder |
| RS149360920 |
OPA3
|
Health Risk |
Conflicting classifications of pathogenicity |
Optic atrophy 3, 3-Methylglutaconic aciduria type 3 |
| RS149362446 |
BBS9
|
Health Risk |
Conflicting classifications of pathogenicity |
Bardet-Biedl syndrome, BBS9-related disorder |
| RS149362508 |
SETX
|
Health Risk |
Conflicting classifications of pathogenicity |
Amyotrophic lateral sclerosis type 4, Spinocerebellar ataxia |
| RS149362848 |
SLC4A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, 11 conditions |
| RS149363953 |
WNT7A
|
Health Risk |
Conflicting classifications of pathogenicity |
WNT7A-related disorder, WNT7A-related disorder |
| RS149364097 |
BRIP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia complementation group J, Hereditary cancer-predisposing syndrome |
| RS149364215 |
ERCC4
|
Health Risk |
Likely pathogenic |
Fanconi anemia complementation group Q, Cockayne syndrome |
| RS149364914 |
COQ8A
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS149364992 |
DNAH11
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia, Primary ciliary dyskinesia 7 |
| RS149365469 |
ACD
|
Health Risk |
Conflicting classifications of pathogenicity |
Dyskeratosis congenita, autosomal dominant 6 |
| RS149366137 |
C2CD3
|
Health Risk |
Pathogenic/Likely pathogenic |
Orofaciodigital syndrome type 14, Malignant tumor of urinary bladder |
| RS149368374 |
ODAD2
|
Health Risk |
Pathogenic/Likely pathogenic |
Primary ciliary dyskinesia 23, Primary ciliary dyskinesia |
| RS149368999 |
F12
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary angioedema type 3, Factor XII deficiency disease |
| RS149369902 |
BAAT
|
Health Risk |
Conflicting classifications of pathogenicity |
BAAT-related disorder, BAAT-related disorder |
| RS149370622 |
COLQ
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital myasthenic syndrome 5, Congenital myasthenic syndrome 5 |
| RS149371094 |
ARHGEF15
|
Health Risk |
Conflicting classifications of pathogenicity |
Early-infantile DEE, Early-infantile DEE |
| RS149372969 |
ATP13A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Kufor-Rakeb syndrome, Autosomal recessive spastic paraplegia type 78 |
| RS149373164 |
FAT4
|
Health Risk |
Conflicting classifications of pathogenicity |
FAT4-related disorder, Van Maldergem syndrome 2 |
| RS149375186 |
COL2A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS149375515 |
EGFR
|
Health Risk |
Conflicting classifications of pathogenicity |
EGFR-related lung cancer, Hereditary cancer-predisposing syndrome |
| RS149375775 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS149378938 |
VARS1
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder with microcephaly, seizures |
| RS149379900 |
PIGV
|
Health Risk |
Conflicting classifications of pathogenicity |
Hyperphosphatasia with intellectual disability syndrome 1, PIGV-related disorder |
| RS149380104 |
PDE6A
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS149380763 |
MEFV
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial Mediterranean fever, Autoinflammatory syndrome |
| RS149380994 |
EP300
|
Health Risk |
Conflicting classifications of pathogenicity |
EP300-related disorder, Rubinstein-Taybi syndrome due to EP300 haploinsufficiency |
| RS149381805 |
PIK3AP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Infantile spasms, Infantile spasms |
| RS149381884 |
ABCA4
|
Health Risk |
Pathogenic |
— |
| RS149382642 |
ERCC6
|
Health Risk |
Conflicting classifications of pathogenicity |
Cockayne syndrome type 2, Age related macular degeneration 5 |
| RS149382836 |
BCS1L
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Colorectal cancer |
| RS149383809 |
MEN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Multiple endocrine neoplasia, type 1 |
| RS149384350 |
PCDH15
|
Health Risk |
Conflicting classifications of pathogenicity |
Usher syndrome type 1F, Inborn genetic diseases |
| RS149384771 |
GAA
|
Health Risk |
Conflicting classifications of pathogenicity |
Glycogen storage disease, type II |
| RS149384863 |
NEB
|
Health Risk |
Conflicting classifications of pathogenicity |
Nemaline myopathy 2, Inborn genetic diseases |
| RS149385240 |
MTTP
|
Health Risk |
Pathogenic |
— |
| RS149386446 |
DYSF
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Autosomal recessive limb-girdle muscular dystrophy type 2B |
| RS149386750 |
MYH7
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypertrophic cardiomyopathy 1, MYH7-related skeletal myopathy |
| RS149388130 |
FANCA
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia, Fanconi anemia complementation group A |
| RS149388376 |
WNK1
|
Health Risk |
Conflicting classifications of pathogenicity |
Pseudohypoaldosteronism type 2C, Neuropathy |
| RS149388680 |
KMT2C
|
Health Risk |
Conflicting classifications of pathogenicity |
— |